CGT-4859

N/A

Report date: 2025/01/16 20:00:08
NME

Base Information

Drug NameCGT-4859
Drug Alias NameCGT4859CGT-4859
ClassificationSmall molecules
Mechanisms of ActionFibroblast growth factor receptor 2 inhibitors
TargetsFibroblast growth factor receptor 2
Therapy Area/IndicationsSolid tumoursCholangiocarcinomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCogent Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesCogent Biosciences Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursCholangiocarcinoma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A